Shiseido is Officially Cleared to Start RCH-01 Trial

Time to see what this is all about


Replicel’s hair growth therapy, RCH-01, has officially received approval by Japanese regulatory authorities to be used in a clinical trial that is now launching. We did hear some rumblings recently that Shiseido was putting the final touches on it’s clinical trial to take place at the Tokyo Medical University Hospital and Toho University Ohasi Medical Center. Now it’s official. Have at it Shiseido, and best wishes from Follicle Thought.

There are 29 comments Join the conversation

Join the conversation

Your email address will not be published. Required fields are marked *

%d bloggers like this: